7

STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title

Download PDF Report

Upload
others
View
7
Download
0

Embed Size (px)

Citation preview

Page 1: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title

Page 2: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title

Page 3: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title

Page 4: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title

Page 5: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title

Page 6: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title

Page 7: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title

Current situation on nonclinical safety evaluation of

Current situation on nonclinical safety evaluation of

Documents

Intellectual Property Considerations During Nonclinical Drug Development

Intellectual Property Considerations During Nonclinical Drug Development

Documents

ERIVANCE METASTATIC BCC CASE STUDY - Erivedge · 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 Pharmacodynamics Pharmacokinetics 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis,

ERIVANCE METASTATIC BCC CASE STUDY - Erivedge · 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 Pharmacodynamics Pharmacokinetics 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis,

Documents

Nonclinical Safety Assessment of Biotherapeutics 11... · o ICH S9 [Nonclinical evaluation for anticancer pharmaceuticals] o ICH M3(R2) [Guidance on nonclinical safety studies for

Nonclinical Safety Assessment of Biotherapeutics 11... · o ICH S9 [Nonclinical evaluation for anticancer pharmaceuticals] o ICH M3(R2) [Guidance on nonclinical safety studies for

Documents

MODULE 2.4 NONCLINICAL OVERVIEW - ansm.sante.fr

MODULE 2.4 NONCLINICAL OVERVIEW - ansm.sante.fr

Documents

MODULE 2.4 NONCLINICAL OVERVIEW...Module 4 XML Backbone Validation The justification for the Module 4 sections for which no nonclinical study reports are available is discussed in

MODULE 2.4 NONCLINICAL OVERVIEW...Module 4 XML Backbone Validation The justification for the Module 4 sections for which no nonclinical study reports are available is discussed in

Documents

Pharmacology/Toxicology in the Investigator’s Brochure · • S9 Nonclinical Evaluation for Anticancer Pharmaceuticals • M3 Nonclinical Safety Studies for the conduct of Human

Pharmacology/Toxicology in the Investigator’s Brochure · • S9 Nonclinical Evaluation for Anticancer Pharmaceuticals • M3 Nonclinical Safety Studies for the conduct of Human

Documents

Nonclinical Evaluation Report

Nonclinical Evaluation Report

Documents

NONCLINICAL CONSIDERATIONS FOR CELL & …...| Nonclinical Development Considerations for C&G Therapies Cell-based Therapies (Regenerative Medicinal Products) • Process of replacing,

NONCLINICAL CONSIDERATIONS FOR CELL & …...| Nonclinical Development Considerations for C&G Therapies Cell-based Therapies (Regenerative Medicinal Products) • Process of replacing,

Documents

ICH guideline S12 on nonclinical biodistribution

ICH guideline S12 on nonclinical biodistribution

Documents

NONCLINICAL CONSIDERATIONS FOR CELL & GENE THERAPIES · laboratory and safely implant. Gene Therapies • Technique for correcting defective genes ... Nonclinical Development Considerations

NONCLINICAL CONSIDERATIONS FOR CELL & GENE THERAPIES · laboratory and safely implant. Gene Therapies • Technique for correcting defective genes ... Nonclinical Development Considerations

Documents

Overview: What nonclinical studies are available to ... What nonclinical studies are ... exploratory evaluation during lead optimization ... What nonclinical studies are available

Overview: What nonclinical studies are available to ... What nonclinical studies are ... exploratory evaluation during lead optimization ... What nonclinical studies are available

Documents

Nonclinical Drug Development - pcp.nihtraining.com · Nonclinical Drug Development Chris H. Takimoto, MD, PhD, ... – Targeted therapies/Biomarkers ... –Selective –Predictable

Nonclinical Drug Development - pcp.nihtraining.com · Nonclinical Drug Development Chris H. Takimoto, MD, PhD, ... – Targeted therapies/Biomarkers ... –Selective –Predictable

Documents

Guidelines on the nonclinical evaluation of vaccine

Guidelines on the nonclinical evaluation of vaccine

Documents

REG Small Airways Study Group Meeting

REG Small Airways Study Group Meeting

Healthcare

MODULE 2.4 NONCLINICAL OVERVIEW - 独立行政法人 ...€¦ · confidential m2.4. nonclinical overview 2012n153960_00 2 table of contents page 1. overview of the nonclinical testing

MODULE 2.4 NONCLINICAL OVERVIEW - 独立行政法人 ...€¦ · confidential m2.4. nonclinical overview 2012n153960_00 2 table of contents page 1. overview of the nonclinical testing

Documents

MODULE 2.4. NONCLINICAL OVERVIEW

MODULE 2.4. NONCLINICAL OVERVIEW

Documents

S9 Nonclinical Evaluation for Anticancer Pharmaceuticals …... · 2018-06-17 · S9 Nonclinical Evaluation for Anticancer Pharmaceuticals Questions and Answers Guidance for Industry

S9 Nonclinical Evaluation for Anticancer Pharmaceuticals …... · 2018-06-17 · S9 Nonclinical Evaluation for Anticancer Pharmaceuticals Questions and Answers Guidance for Industry

Documents

Nonclinical Safety Evaluation of Inhalation Drug Products · Nonclinical Safety Evaluation of Inhalation Drug Products February ... an increasingly popular route of drug ... The nonclinical

Nonclinical Safety Evaluation of Inhalation Drug Products · Nonclinical Safety Evaluation of Inhalation Drug Products February ... an increasingly popular route of drug ... The nonclinical

Documents

Nonclinical evaluation of oral antiviral agents...– Which population to study • Naives, relapsers, partial/null responders, genotype, IL28B polymorphism? – Sustained virological

Nonclinical evaluation of oral antiviral agents...– Which population to study • Naives, relapsers, partial/null responders, genotype, IL28B polymorphism? – Sustained virological

Documents

2013 REG Last Minute Study Notes (Bonus)

2013 REG Last Minute Study Notes (Bonus)

Documents

NONCLINICAL CONSIDERATIONS FOR CELL & GENE THERAPIES

NONCLINICAL CONSIDERATIONS FOR CELL & GENE THERAPIES

Documents

DARUNAVIR/COBICISTAT MODULE 2.4 NONCLINICAL OVERVIEW

DARUNAVIR/COBICISTAT MODULE 2.4 NONCLINICAL OVERVIEW

Documents

Nonclinical approaches to study shedding of gene therapy ...Nonclinical approaches to study shedding of gene therapy vectors E.S. van Amersfoort, PhD. Shedding as preclinical issue

Nonclinical approaches to study shedding of gene therapy ...Nonclinical approaches to study shedding of gene therapy vectors E.S. van Amersfoort, PhD. Shedding as preclinical issue

Documents

TRAINING COURSE ONCOLOGY NONCLINICAL DEVELOPMENT …

TRAINING COURSE ONCOLOGY NONCLINICAL DEVELOPMENT …

Documents

For Teeth Requiring Endodontic Treatment, What Are the … · 2017-10-27 · First selection Single-tooth implants reported Nonclinical study Clinical study Case report Follow-up

For Teeth Requiring Endodontic Treatment, What Are the … · 2017-10-27 · First selection Single-tooth implants reported Nonclinical study Clinical study Case report Follow-up

Documents

UNWANTED INTRUSIVE THOUGHTS IN NONCLINICAL INDIVIDUALS

UNWANTED INTRUSIVE THOUGHTS IN NONCLINICAL INDIVIDUALS

Documents

2.6.3 NONCLINICAL PHARMACOLOGY TABULATED SUMMARY€¦ · 2.6.3 NONCLINICAL PHARMACOLOGY TABULATED SUMMARY ... Pharmacology tabulated summary - pharmacology overview . Test Article:

2.6.3 NONCLINICAL PHARMACOLOGY TABULATED SUMMARY€¦ · 2.6.3 NONCLINICAL PHARMACOLOGY TABULATED SUMMARY ... Pharmacology tabulated summary - pharmacology overview . Test Article:

Documents

2.4 Nonclinical Overview

2.4 Nonclinical Overview

Documents

Nonclinical Data Assessment and Strategic Planning

Nonclinical Data Assessment and Strategic Planning

Documents